BBB National Programs Newsroom

Optivida Silver Solution Discontinued COVID-19 Cure, Efficacy, and Safety Claims Following NAD Inquiry

For Immediate Release 

New York, NY – June 8, 2020 – Following an inquiry by the National Advertising Division (NAD), Optivida Health removed social media posts that referred to the Jim Bakker Show and claims by Mr. Bakker about Optivida Silver Solution, a liquid dietary supplement, curing COVID-19. NAD also recommended that the advertiser discontinue express efficacy and safety claims about Optivida Silver Solution. 

Through a routine monitoring program, NAD challenged a Twitter post featuring a video of televangelist Jim Bakker selling a silver solution referenced as Optivida Silver Solution, touting it as a treatment or cure for COVID-19. NAD monitors national advertising in different media as part of its public interest mission to ensure the truthfulness and accuracy of national advertising. NAD’s monitoring efforts are currently focused on advertising of dietary supplements and other products making express or implied claims that they can boost one’s immunity to provide protection against COVID-19. 

In response to NAD’s inquiry, the advertiser informed NAD that the Jim Bakker video was permanently discontinued as a result of law enforcement cease and desist orders. NAD appreciated the advertiser’s written assurances and evidence demonstrating that the Jim Bakker Show does not sell the product in question prior to NAD’s initiation of this inquiry. The advertiser removed the social media posts identified by NAD which refer to the Jim Bakker Show and claims by Mr. Bakker about Optivida Silver Solution curing COVID-19. NAD noted that these voluntarily discontinued posts with the offending claims will be treated, for compliance purposes, as though NAD recommended their discontinuance and the advertiser agreed to comply.  

Further, NAD requested substantiation for the unqualified superior health-related efficacy claim that “Optivida Silver Solution (10 ppm) works faster, longer, and more efficiently than other silvers to support your immune system.” In support of the claim, the advertiser referred to an excerpt from a book entitled “Silver: Nature’s Natural Healer” and marketing materials from its manufacturer. However, NAD determined that these do not constitute competent and reliable scientific evidence, nor do they cite any studies to support the claim that Optivida Silver Solution works faster, longer, and more efficiently to support immune health than competing silver-based supplements. Therefore, NAD recommended that the claim be discontinued. NAD noted that nothing in its decision prevents the advertiser from truthfully explaining compositional differences between its product and competing products without expressly or impliedly conveying that these differences confer any health-related benefits. 

NAD also requested substantiation for the safety claim “Silver is safe – no negative action on organs or other body systems when ingested or used topically; no negative interactions with other drugs when ingested; no damage to probiotic systems; safe for children, infants, animals.” In support of the claim, the advertiser submitted four studies and one review article. However, after careful consideration of the submitted materials, NAD determined that they do not support the challenged claim and recommended that it be discontinued. 

In its advertiser’s statement, Optivida Health stated that it will comply with NAD’s recommendations. The advertiser stated that it believes “that there are many critical differences that consumers should know when they are comparing our product with other competing products. However, we will seek other ways to truthfully explain these structural differences without implying health-related benefits.”  

Optivida Silver Solution Discontinued COVID-19 Cure, Efficacy, and Safety Claims Following NAD Inquiry

For Immediate Release 

New York, NY – June 8, 2020 – Following an inquiry by the National Advertising Division (NAD), Optivida Health removed social media posts that referred to the Jim Bakker Show and claims by Mr. Bakker about Optivida Silver Solution, a liquid dietary supplement, curing COVID-19. NAD also recommended that the advertiser discontinue express efficacy and safety claims about Optivida Silver Solution. 

Through a routine monitoring program, NAD challenged a Twitter post featuring a video of televangelist Jim Bakker selling a silver solution referenced as Optivida Silver Solution, touting it as a treatment or cure for COVID-19. NAD monitors national advertising in different media as part of its public interest mission to ensure the truthfulness and accuracy of national advertising. NAD’s monitoring efforts are currently focused on advertising of dietary supplements and other products making express or implied claims that they can boost one’s immunity to provide protection against COVID-19. 

In response to NAD’s inquiry, the advertiser informed NAD that the Jim Bakker video was permanently discontinued as a result of law enforcement cease and desist orders. NAD appreciated the advertiser’s written assurances and evidence demonstrating that the Jim Bakker Show does not sell the product in question prior to NAD’s initiation of this inquiry. The advertiser removed the social media posts identified by NAD which refer to the Jim Bakker Show and claims by Mr. Bakker about Optivida Silver Solution curing COVID-19. NAD noted that these voluntarily discontinued posts with the offending claims will be treated, for compliance purposes, as though NAD recommended their discontinuance and the advertiser agreed to comply.  

Further, NAD requested substantiation for the unqualified superior health-related efficacy claim that “Optivida Silver Solution (10 ppm) works faster, longer, and more efficiently than other silvers to support your immune system.” In support of the claim, the advertiser referred to an excerpt from a book entitled “Silver: Nature’s Natural Healer” and marketing materials from its manufacturer. However, NAD determined that these do not constitute competent and reliable scientific evidence, nor do they cite any studies to support the claim that Optivida Silver Solution works faster, longer, and more efficiently to support immune health than competing silver-based supplements. Therefore, NAD recommended that the claim be discontinued. NAD noted that nothing in its decision prevents the advertiser from truthfully explaining compositional differences between its product and competing products without expressly or impliedly conveying that these differences confer any health-related benefits. 

NAD also requested substantiation for the safety claim “Silver is safe – no negative action on organs or other body systems when ingested or used topically; no negative interactions with other drugs when ingested; no damage to probiotic systems; safe for children, infants, animals.” In support of the claim, the advertiser submitted four studies and one review article. However, after careful consideration of the submitted materials, NAD determined that they do not support the challenged claim and recommended that it be discontinued. 

In its advertiser’s statement, Optivida Health stated that it will comply with NAD’s recommendations. The advertiser stated that it believes “that there are many critical differences that consumers should know when they are comparing our product with other competing products. However, we will seek other ways to truthfully explain these structural differences without implying health-related benefits.”  

Blog

What to Know About the North Carolina Lemon Law

Next in our blog series reviewing the state lemon laws is the Tarheel State – North Carolina. In this series, we break down what the lemon law does and does not cover in each state because although there is a federal lemon law, called the Magnuson-Moss Warranty Act, states also have their own laws to help consumers who purchase defective vehicles.
Read more
Blog

Top 10 Reasons to Resolve Lemon Law Disputes with BBB AUTO LINE

If your vehicle is still under warranty and you have an issue that the dealership has been unable to resolve, you may be able to reach a resolution directly with the manufacturer – at no cost to you - through BBB AUTO LINE. We have assembled a list of ten ways BBB AUTO LINE provides optimal resolution solutions.
Read more
Blog

What to Know About the New York Lemon Law

As we continue our blog series reviewing state lemon laws, we turn our attention to New York State. True to its reputation for making its own rules, New York includes some distinctive aspects within its lemon laws.
Read more
Blog

Defining The 'S' In ESG And Navigating Disclosures

For businesses interested in making robust ESG disclosures, not only can the sheer number of frameworks and standards make ESG performance reporting seem overwhelming, the frameworks themselves can be a bit fuzzy on how they define and measure the "S" of ESG.
Read more

Optivida Silver Solution Discontinued COVID-19 Cure, Efficacy, and Safety Claims Following NAD Inquiry

For Immediate Release 

New York, NY – June 8, 2020 – Following an inquiry by the National Advertising Division (NAD), Optivida Health removed social media posts that referred to the Jim Bakker Show and claims by Mr. Bakker about Optivida Silver Solution, a liquid dietary supplement, curing COVID-19. NAD also recommended that the advertiser discontinue express efficacy and safety claims about Optivida Silver Solution. 

Through a routine monitoring program, NAD challenged a Twitter post featuring a video of televangelist Jim Bakker selling a silver solution referenced as Optivida Silver Solution, touting it as a treatment or cure for COVID-19. NAD monitors national advertising in different media as part of its public interest mission to ensure the truthfulness and accuracy of national advertising. NAD’s monitoring efforts are currently focused on advertising of dietary supplements and other products making express or implied claims that they can boost one’s immunity to provide protection against COVID-19. 

In response to NAD’s inquiry, the advertiser informed NAD that the Jim Bakker video was permanently discontinued as a result of law enforcement cease and desist orders. NAD appreciated the advertiser’s written assurances and evidence demonstrating that the Jim Bakker Show does not sell the product in question prior to NAD’s initiation of this inquiry. The advertiser removed the social media posts identified by NAD which refer to the Jim Bakker Show and claims by Mr. Bakker about Optivida Silver Solution curing COVID-19. NAD noted that these voluntarily discontinued posts with the offending claims will be treated, for compliance purposes, as though NAD recommended their discontinuance and the advertiser agreed to comply.  

Further, NAD requested substantiation for the unqualified superior health-related efficacy claim that “Optivida Silver Solution (10 ppm) works faster, longer, and more efficiently than other silvers to support your immune system.” In support of the claim, the advertiser referred to an excerpt from a book entitled “Silver: Nature’s Natural Healer” and marketing materials from its manufacturer. However, NAD determined that these do not constitute competent and reliable scientific evidence, nor do they cite any studies to support the claim that Optivida Silver Solution works faster, longer, and more efficiently to support immune health than competing silver-based supplements. Therefore, NAD recommended that the claim be discontinued. NAD noted that nothing in its decision prevents the advertiser from truthfully explaining compositional differences between its product and competing products without expressly or impliedly conveying that these differences confer any health-related benefits. 

NAD also requested substantiation for the safety claim “Silver is safe – no negative action on organs or other body systems when ingested or used topically; no negative interactions with other drugs when ingested; no damage to probiotic systems; safe for children, infants, animals.” In support of the claim, the advertiser submitted four studies and one review article. However, after careful consideration of the submitted materials, NAD determined that they do not support the challenged claim and recommended that it be discontinued. 

In its advertiser’s statement, Optivida Health stated that it will comply with NAD’s recommendations. The advertiser stated that it believes “that there are many critical differences that consumers should know when they are comparing our product with other competing products. However, we will seek other ways to truthfully explain these structural differences without implying health-related benefits.”  

 

 

Media Inquiry